Open Access
Issue
EPJ Web Conf.
Volume 239, 2020
ND 2019: International Conference on Nuclear Data for Science and Technology
Article Number 23001
Number of page(s) 6
Section Medical Radioisotopes Properties and Production
DOI https://doi.org/10.1051/epjconf/202023923001
Published online 30 September 2020
  1. F. Mota et al., Sensitivity of IFMIF-DONES irradiation characteristics to different design parameters Nucl. Fusion 55 (2015). [Google Scholar]
  2. http://www.roadmap2018.esfri.eu/projects-and-landmarks/browse-the-catalogue/ifmif-dones/ [Google Scholar]
  3. J. Knaster et al., IFMIF, the European-Japanese ef-fors under the Broader Approach agreement towards a Li(d, xn) neutron source: Current status and future options, Nucl. Materials and Energy 9 (2016) 46-54. [Google Scholar]
  4. A. Maj et al., White Book on the Complementary Scientific Programme at IFMIF-DONES. www.ifj.edu.pl/publ/reports/2016/ [Google Scholar]
  5. F. Arias de Saavedra, I. Porras and J. Praena, Routes for the production of isotopes for PET with high intensity deuteron accelerators. Nuclear Inst. and Methods in Physics Research, A 887 (2018) 50-53. [CrossRef] [Google Scholar]
  6. S. Pommé et al., Measurement of the 177Lu Half-life, Applied Rad. and Isotopes. 69 (2011) 1267-1273. [Google Scholar]
  7. https://www-nds.iaea.org/relnsd/vcharthtml/VChartHTML.html [Google Scholar]
  8. M. Weineisen, M. Schottelius et al., 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA targeted theranostic concept and first proof of concept human studies, Journal of Nuclear Medicine 56 (2015) 1169-1176. [Google Scholar]
  9. J. Kwekkeboom, W. de Herder et al., Treatment With the Radio labeled Somatostatin Analog [ 177Lu-DOTA0,Tyr3] Octreotate: Toxicity, Efficacy, and Survival, Journal of Clinical Oncology. 28 (2008) 2124-2130. [Google Scholar]
  10. J. Kwekkeboom, J. Teunissen et al., Radiolabeled Somatostatin Analog [177Lu- DOTA0,Tyr3] Octreo-tate in Patients With Endocrine Gastroenteropan-creatic Tumors, J. of Clinical Oncology. 23 (2005) 2754-2762. [Google Scholar]
  11. J. Strosberg, et al., Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors, The New England J. of Medicine. 376 (2017) 125-135. [Google Scholar]
  12. M.R.A Pillai, S. Chakraborty, T. Das, M. Venkatesh, N. Ramamoorthy. Production logistics of 177Lu for radionuclidetherapy. Applied Radiation and Isotopes 59 (2-3), 109-118 (2003). [Google Scholar]
  13. A. Dash et al., Production of 177Lu for Targeted Radionuclide Therapy: Available Options, Nuclear Medicine Molecular Imaging 49 (2015) 85-107. [Google Scholar]
  14. H.H. Andersen, J.F. Ziegler, Stopping Powers and Ranges in All Elements, Pergamon Press, NY, 1985. [Google Scholar]
  15. http://www.srim.org/ [Google Scholar]
  16. A. Hermanne et al., Deuteron-induced reactions on Yb: Measured cross sections and rationale for production pathways of carrier-free, medically relevant radionuclides, Nuclear Instruments and Methods in Physics Research B. 247 (2006) 223-231. [Google Scholar]
  17. S. Manenti et al., Excitation function for deuteron induced nuclear reactions on natural ytterbium for production of high specific activity 177gLu in no-carrier-added form for metabolic radiotherapy, Applied Radiation and Isotopes. 69 (2011) 37-45. [Google Scholar]
  18. J.H. Lienhard IV, J. H. Lienhard V. A heat transfer text book. 3rd ed. Cambridge, MA. Phlogiston, Press, c2008. [Google Scholar]
  19. Ashutosh Dash, Maroor Raghavan Ambikalmajan Pillai, Furn F. Knapp Jr.. Review. Production of 177Lu for Targeted Radionuclide Therapy: Available Options. Nucl. Med. Mol. Imaging (2015) 49:85-107. [Google Scholar]
  20. Leilei Sun, et al., Phase stability and thermal conductivity of ytterbia and yttria co-dopedzirconia. Progress in Natural Science: Materials International 2013 ; 23(4) :440-445. [Google Scholar]
  21. Agencia Española de Medicamentos y Productos Sanitarios, Spanish Government, https://cima.aemps.es/cima/publico/home.html [Google Scholar]
  22. https://www.nndc.bnl.gov/exfor/exfor.htm [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.